Fortitude Family Office’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.3K Buy
276
+6
+2% +$525 ﹤0.01% 463
2026
Q1
$23K Buy
270
+102
+61% +$9.09K 0.01% 397
2025
Q4
$13.3K Sell
168
-53
-24% -$4.16K ﹤0.01% 496
2025
Q3
$17.7K Buy
221
+19
+9% +$1.62K ﹤0.01% 421
2025
Q2
$18.4K Sell
202
-100
-33% -$9.13K 0.01% 391
2025
Q1
$28.3K Sell
302
-200
-40% -$17.9K 0.01% 323
2024
Q4
$45.6K Buy
502
+1
+0.2% +$95 0.02% 271
2024
Q3
$52K Sell
501
-2,550
-84% -$260K 0.02% 238
2024
Q2
$296K Hold
3,051
0.17% 69
2024
Q1
$275K Sell
3,051
-345
-10% -$29.2K 0.18% 69
2023
Q4
$271K Buy
+3,396
New +$255K 0.2% 69

Other funds holding CL

Fortitude Family Office's CL Position: Q2 2026 in Review

Fortitude Family Office increased its Colgate-Palmolive (CL) stake by 2.2% in Q2 2026, buying an estimated $525 and bringing the position to 276 shares worth $25.3K. The position accounts for ﹤0.01% of the portfolio, ranked #463.

Fortitude Family Office first reported a position in CL in Q4 2023 and has held it in 11 quarters since. The position peaked at $296K in Q2 2024. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Fortitude Family Office held 276 shares of Colgate-Palmolive worth $25.3K as of Q2 2026.
  • Fortitude Family Office bought 6 Colgate-Palmolive shares in Q2 2026, an estimated $525.
  • Colgate-Palmolive made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #463 holding.
  • Fortitude Family Office first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 11 quarters since.
  • Fortitude Family Office's Colgate-Palmolive position peaked at $296K in Q2 2024.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.